Original Research

Accepted on 25 Nov 2024

Prognostic Significance of Combined PD-L1 Expression in Malignant and Infiltrating Cells in Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab

in Cancer Immunity and Immunotherapy

Jaejun Lee
Jae-Sung Yoo
Ji Hoon Kim
Dong Yeup Lee
Keungmo Yang
Bohyun Kim
Joon-Il Choi
Jeong Won Jang
Jong Young Choi
Seung Kew Yoon

Frontiers in Immunology

doi 10.3389/fimmu.2024.1506355

Original Research

Accepted on 25 Nov 2024

Multi-omics analysis and experiments uncover the function of cancer stemness in ovarian cancer and establish a machine learning-based model for predicting immunotherapy responses

in Cancer Immunity and Immunotherapy

Zhibing Liu
Lei Han
Xiaoyu Ji
Xiaole Wang
Jinbo Jian
Yujie Zhai
Yingjiang Xu
Feng Wang
Xiuwen Wang
Fangling Ning

Frontiers in Immunology

doi 10.3389/fimmu.2024.1486652

Opinion

Accepted on 25 Nov 2024

Revisiting Immune Checkpoint Inhibitors: New Strategies to Enhance Efficacy and Reduce Toxicity

in Cancer Immunity and Immunotherapy

Hongfei Jiang
Dianying Zhang
Jingjing Zhao
Dan Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1490129

Original Research

Accepted on 25 Nov 2024

Integrating machine learning, bioinformatics and experimental verification to identify a novel prognostic marker associated with tumor immune microenvironment in head and neck squamous carcinoma cell

in Cancer Immunity and Immunotherapy

Xiaoxia Zeng
Dunhui Yang
Jin Zhang
Kang Li
Xijia Wang
Fang Ma
Xianqin Liao
Zhen Wang
Xianhai Zeng
Peng Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1501486

Original Research

Accepted on 25 Nov 2024

Assessing Immunotherapy Response: Going Beyond RECIST by Integrating Early Tumor Growth Kinetics

in Cancer Immunity and Immunotherapy

Mehdi FELFLI
Antoine IANNESSI
Alexandre THINNES
Sebastien Jacques JACQUES
Yan LIU

Frontiers in Immunology

doi 10.3389/fimmu.2024.1470555

Original Research

Accepted on 25 Nov 2024

Mitochondria-Associated Programmed Cell Death: Elucidating Prognostic Biomarkers, Immune Checkpoints, and Therapeutic Avenues in Multiple Myeloma

in Cancer Immunity and Immunotherapy

Gongzhizi Gao
Jiyu Miao
Yachun Jia
Aili He

Frontiers in Immunology

doi 10.3389/fimmu.2024.1448764

Review

Accepted on 25 Nov 2024

Alternative Splicing of Modulatory Immune Receptors in T Lymphocytes: A Newly Identified and Targetable Mechanism for Anticancer Immunotherapy

in Cancer Immunity and Immunotherapy

Shoshana Frankenburg
Michal Lotem
Ori Stern
Elad Zisman
Shay Tzaban

Frontiers in Immunology

doi 10.3389/fimmu.2024.1490035

Original Research

Accepted on 25 Nov 2024

Impact of steroid-sparing immunosuppressive agents on tumor outcome in the context of cancer immunotherapy with highlight on melanoma: A systematic literature review and meta-analysis

in Cancer Immunity and Immunotherapy

Jennifer Strouse
Karmela Kimi Chan
Rachel Baccile
Gong He
Diana K.N. Louden
Mihai Giurcanu
Arohi Singh
John Rieth
Noha Abdel-Wahab
Tamiko Katsumoto

Frontiers in Immunology

doi 10.3389/fimmu.2024.1499478

Review

Accepted on 25 Nov 2024

Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review

in Cancer Immunity and Immunotherapy

Lucía Serrano García
Beatriz Jávega
Antonio Llombart-Cussac
María Gión
José Manuel Pérez-García
Javier Cortés
Leonor Fernández-Murga

Frontiers in Immunology

doi 10.3389/fimmu.2024.1513421

Original Research

Accepted on 25 Nov 2024

Diagnostic value of multi-tumor-associated autoantibody expression in esophageal squamous cell carcinoma and correlation of clinical features

in Cancer Immunity and Immunotherapy

Sihao Zhou
Kejun Liu
Yuyu Yang
Chuan Yuan
Yi Liu
Yi Liang
Wenhao Li
Jingjing Zhang
Hongyu Ye
Sheng Gong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1518431

Brief Research Report

Accepted on 25 Nov 2024

Adjuvant immunotherapy after neoadjuvant immunochemotherapy and esophagectomy for esophageal squamous cell carcinoma: a real-world study

in Cancer Immunity and Immunotherapy

Ji-Feng Feng
Liang Wang
Xun Yang
Qi-Xun Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1456193

Case Report

Accepted on 25 Nov 2024

Case Report: Systemic Sclerosis During Neoadjuvant Therapy for Breast Cancer in a 59-Year-Old Woman

in Cancer Immunity and Immunotherapy

Siyu Liu
Xiaomei Xiao
Fangjing Yue
Cong Su
Yujun Tong
Weiyun Xu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1487508

Original Research

Accepted on 25 Nov 2024

SOX13 as a Potential Prognostic Biomarker Linked to Immune Infiltration and Ferroptosis Inhibits the Proliferation, Migration, and Metastasis of Thyroid Cancer Cells

in Cancer Immunity and Immunotherapy

Yan-Yan Ma
Wei-Ye Zhou
Yue Qian
Ying-Ying Mu
Wei Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1478395

Original Research

Published on 25 Nov 2024

Cost-effectiveness analysis of benmelstobart, anlotinib, and chemotherapy in extensive-stage small-cell lung cancer

in Cancer Immunity and Immunotherapy

Maojin You
Lingling Luo
Tingting Lu
Shaofang Chen
Ying He

Frontiers in Immunology

doi 10.3389/fimmu.2024.1477146

273 views

Brief Research Report

Published on 25 Nov 2024

Associations between glycan signature alterations and the cellular antigenic properties of passaged chondrocytes

in Cancer Immunity and Immunotherapy

Kentaro Homan
Taiki Tokuhiro
Tomohiro Onodera
Hisatoshi Hanamatsu
Jun-ichi Furukawa
Taku Ebata
Masatake Matsuoka
Ken Kadoya
M. Alaa Terkawi
Norimasa Iwasaki

Frontiers in Immunology

doi 10.3389/fimmu.2024.1475473

Original Research

Published on 25 Nov 2024

The monitoring of B lymphocytes in non-lymphoma patients following rituximab treatment

in Cancer Immunity and Immunotherapy

Linjie Dong
Lin Yan
Yi Li
Mei Li
Weihua Feng
Xiaoqiong Li
Jiaxi Yue
Erdi Zhang
Yao Luo
Yangjuan Bai

Frontiers in Immunology

doi 10.3389/fimmu.2024.1513303

Navigation group

Articles

Prognostic Significance of Combined PD-L1 Expression in Malignant and Infiltrating Cells in Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab

Multi-omics analysis and experiments uncover the function of cancer stemness in ovarian cancer and establish a machine learning-based model for predicting immunotherapy responses

Revisiting Immune Checkpoint Inhibitors: New Strategies to Enhance Efficacy and Reduce Toxicity

Integrating machine learning, bioinformatics and experimental verification to identify a novel prognostic marker associated with tumor immune microenvironment in head and neck squamous carcinoma cell

Assessing Immunotherapy Response: Going Beyond RECIST by Integrating Early Tumor Growth Kinetics

Mitochondria-Associated Programmed Cell Death: Elucidating Prognostic Biomarkers, Immune Checkpoints, and Therapeutic Avenues in Multiple Myeloma

Alternative Splicing of Modulatory Immune Receptors in T Lymphocytes: A Newly Identified and Targetable Mechanism for Anticancer Immunotherapy

Impact of steroid-sparing immunosuppressive agents on tumor outcome in the context of cancer immunotherapy with highlight on melanoma: A systematic literature review and meta-analysis

Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review

Diagnostic value of multi-tumor-associated autoantibody expression in esophageal squamous cell carcinoma and correlation of clinical features

Adjuvant immunotherapy after neoadjuvant immunochemotherapy and esophagectomy for esophageal squamous cell carcinoma: a real-world study

Case Report: Systemic Sclerosis During Neoadjuvant Therapy for Breast Cancer in a 59-Year-Old Woman

SOX13 as a Potential Prognostic Biomarker Linked to Immune Infiltration and Ferroptosis Inhibits the Proliferation, Migration, and Metastasis of Thyroid Cancer Cells

Cost-effectiveness analysis of benmelstobart, anlotinib, and chemotherapy in extensive-stage small-cell lung cancer

Associations between glycan signature alterations and the cellular antigenic properties of passaged chondrocytes

The monitoring of B lymphocytes in non-lymphoma patients following rituximab treatment